Clinical picture: leopard-like vitiligo with capecitabine.
Schmid-Wendtner
M H
MH
Department of Dermatology and Allerology, Klinikum Innenstadt, Ludwig-Maximilians University, 80337 Munich, Germany.
Wendtner
C M
CM
Volkenandt
M
M
Heinemann
V
V
D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects* / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy; D000069287:Capecitabine; D003841:Deoxycytidine / Q000009:adverse effects* / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005260:Female; D005472:Fluorouracil / Q000009:adverse effects*; D006801:Humans; D008875:Middle Aged; D014820:Vitiligo / Q000139:chemically induced*
D000964:Antimetabolites, Antineoplastic; D003841:Deoxycytidine; D000069287:Capecitabine; D005472:Fluorouracil